Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14 - Wikidata - wikimedia - TriplyDB

Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14

Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14

http://www.wikidata.org/entity/Q34655503

about

Aflibercept for neovascular age-related macular degeneration Aflibercept for neovascular age-related macular degeneration Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases Severity of visual field loss and health-related quality of life.RESPONSIVENESS OF THE NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE-25 TO VISUAL ACUITY GAINS IN PATIENTS WITH DIABETIC MACULAR EDEMA: Evidence From the RIDE and RISE Trials.Longitudinal changes in visual acuity and health-related quality of life: the Los Angeles Latino Eye study.Impact of age-related macular degeneration on vision-specific quality of life: Follow-up from the 10-year and 15-year visits of the Study of Osteoporotic Fractures Ten-year change in vision-related quality of life in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy.Visual acuity outcomes after cataract surgery in patients with age-related macular degeneration: age-related eye disease study report no. 27 Individualized ranibizumab therapy strategies in year 3 after as-needed treatment for polypoidal choroidal vasculopathy.Quality of life in age-related macular degeneration: a review of the literature.Comorbid cognitive impairment and functional trajectories in low vision rehabilitation for macular disease.Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study.Associations between self-rated vision score, vision tests, and self-reported visual function in the Salisbury Eye Evaluation Study.Relationship between slow visual processing and reading speed in people with macular degeneration.SF-6D utility values for the better- and worse-seeing eye for health states based on the Snellen equivalent in patients with age-related macular degeneration.Asymmetry in keratoconus and vision-related quality of life Psychological and cognitive determinants of vision function in age-related macular degeneration Assessing quality of life in the treatment of patients with age-related macular degeneration: clinical research findings and recommendations for clinical practice.The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration Changes in the quality-of-life of people with keratoconus.Emotional well-being and adjustment to vision loss in later life: a meta-synthesis of qualitative studies.Visual function quality of life measure changes upon conversion to neovascular age-related macular degeneration in second eyes.Quality of life in Nepalese patients with low vision and the impact of low vision services.Impact of Uveitis on Quality of Life in Adult Patients With Juvenile Idiopathic Arthritis.Rasch analysis in the development of a simplified version of the National Eye Institute Visual-Function Questionnaire-25 for utility estimation.A Discussion of Commercially Available Intra-ocular Telescopic Implants for Patients with Age-Related Macular Degeneration.

P2860

Q24186157-23606622-9FF2-4E1F-B091-B4C28BA4A010 Q24193255-7E228901-97D3-40BE-AD9C-0F5805E42ABF Q24242944-7B430EE2-18BD-4C81-9BAA-42ED025DD543 Q30830781-C884BB51-8995-4998-91E4-0EE88B18683E Q33797985-D1A522AF-3759-457D-87D7-9E96062A3801 Q34154769-3E3E8F86-172C-4A5D-A2E3-385069BAEFB5 Q34258664-C3A324C2-6313-4DA1-B03D-9CEBB484EC3A Q34472219-8BA94EC5-7CC9-424C-9A60-E14812CBD662 Q34493282-A3DCDE6F-169F-4970-94EE-B24F922A6CF6 Q35368673-9A7B7750-B77F-4D84-AD8D-D31A4FBEE81D Q35606970-780BD04F-68DE-4021-9A25-448E29E1E507 Q35917267-D56E7F83-9A1A-4691-8FBD-C49AAC4281D7 Q36025824-64CD2C6E-86F6-4D46-BF75-FBAC3AA23BEE Q36111764-27C41B18-AE0B-48F8-9807-E41698AA0363 Q36169954-6680A08B-8BCE-4A0D-857F-1FA7765699F5 Q36287461-394F7F4A-9E4C-4217-B9D0-FA08E5672781 Q36350663-84AAF021-3948-4DEC-8E35-AD2A62FCE2E8 Q36645753-86CB3E8D-8C95-4549-B986-ADBA87687E58 Q36985901-35C13E45-C674-401C-944B-5A5FB56AAED8 Q37297814-6D0ED6ED-562E-4E4B-840B-FE5C050AF7C1 Q37365628-46A79663-34AB-430D-8FB4-79EE392F7308 Q37953959-3276946F-D35B-4D50-9917-167A8492100A Q38867756-08C2EEAC-92B2-4175-BE2A-C85334C07E9C Q46201238-142E47F1-EFF4-48A6-9AA5-9A872A12728E Q47434154-A5B35A9D-7209-47DA-8CE7-C73796387AEF Q48617600-0FB73E61-4B29-4045-B17C-4752A397EB92 Q55470390-38037C88-D51E-4AED-8D5B-72C6747C35AB

P2860

Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14

http://www.wikidata.org/entity/Q34655503

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Responsiveness of the National ...... s opacity: AREDS Report no. 14

@ast

Responsiveness of the National ...... s opacity: AREDS Report no. 14

@en

Responsiveness of the National ...... s opacity: AREDS Report no. 14

@nl

type

label

Responsiveness of the National ...... s opacity: AREDS Report no. 14

@ast

Responsiveness of the National ...... s opacity: AREDS Report no. 14

@en

Responsiveness of the National ...... s opacity: AREDS Report no. 14

@nl

prefLabel

Responsiveness of the National ...... s opacity: AREDS Report no. 14

@ast

Responsiveness of the National ...... s opacity: AREDS Report no. 14

@en

Responsiveness of the National ...... s opacity: AREDS Report no. 14

@nl

P1433

Q34655503-22705D63-D66A-48BB-ABAB-B223AA9F2401

P1476

Q34655503-E846CA36-C10B-465F-9027-29F9782EAAC5

P2093

Q34655503-50A951E0-AFA3-49AA-B10D-7EBF5431D0B7

Q34655503-B2D4644B-7FB9-4782-86A0-FC772CAC4DFA

P2860

Q34655503-0F9F06C6-58E4-4A10-8D4E-7594DAB42B4F

Q34655503-12AFA299-273C-4001-A6C8-AF67ABDB9151

Q34655503-263817AF-E976-4F1B-8D50-F6376E9176B8

Q34655503-36A09C5C-1F74-4F34-88F3-3C549173C574

Q34655503-39D8E89A-6D00-4AF6-83DE-91E1BA7D9C53

Q34655503-478BEDD5-D5BD-473A-81AF-5DAC5E13A49A

Q34655503-5159B852-D0B3-42D0-8DDF-027B29A4AD9E

Q34655503-51CDE909-ED52-43B6-990A-4C750D7AB810

Q34655503-6DCE7FB4-0803-4CC0-94EF-0F7AB51629F3

Q34655503-AD3C0690-3822-4662-88CB-71E1C6E39D35

P304

Q34655503-8B0F3856-0781-4D70-AE01-2016DB20066F

P31

Q34655503-89DF5571-32F3-44AD-843B-6271A23ECDBE

P356

Q34655503-CE40C073-4764-414F-9BD0-AEC7ECA60610

P407

Q34655503-3DE5E75D-861C-4376-8598-369E7600D811

P433

Q34655503-6BAE2C62-3B8B-4C3A-B0E0-D1FBE2A81DC8

P478

Q34655503-D2633105-07E3-4EAD-998C-BDF743571BA4

P577

Q34655503-BBCAE90B-AB8A-472F-ABA6-2AEF6B32B8B4

P5875

Q34655503-CBEE7E2F-95D5-4560-A7E7-0083DB86A1A5

P698

Q34655503-3DF97458-A234-4250-96DC-4ED0F1859866

P921

Q34655503-673CC708-165E-4155-A307-3F4735805CA6

P932

Q34655503-6C18D504-7445-4946-B433-6E7F1CD7AC92

P356

ARCHOPHT.123.9.1207

P1433

JAMA Ophthalmology

P1476

Responsiveness of the National ...... s opacity: AREDS Report no. 14

@en

P2093

Anne S Lindblad

http://www.w3.org/2001/XMLSchema#string

Traci E Clemons

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9

The meaning and use of the area under a receiver operating characteristic (ROC) curve

Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1.

National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10

The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1.

Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature review.

Do patients with age related maculopathy and cataract benefit from cataract surgery?

Basic principles of ROC analysis.

Interpretation of quality of life changes.

P304

1207-1214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHOPHT.123.9.1207

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7604701

http://www.w3.org/2001/XMLSchema#string

P698

16157800

http://www.w3.org/2001/XMLSchema#string

P921

P932

1473207

http://www.w3.org/2001/XMLSchema#string